Reproductive and hormonal sequelae of chemotherapy in women: Premature menopause and impaired fertility can result, effects that are especially disturbing to young women

Cancer Nursing

Volumn 29, Issue 2 SUPPL., 2006, Pages 60-65

  Knobf, M Tish ^a  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AROMATASE INHIBITOR; GONADORELIN AGONIST; TAMOXIFEN; TAMOXIFEN CITRATE; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVOR; CRYOPRESERVATION; EARLY MENOPAUSE; FEMALE FERTILITY; HEALTH CARE QUALITY; HORMONAL THERAPY; HUMAN; INFERTILITY; MEDICAL RESEARCH; OOCYTE; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REPRODUCTION; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SOCIAL ASPECT; TOTAL QUALITY MANAGEMENT; AFTERCARE; AGE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; INFERTILITY THERAPY; INTERPERSONAL COMMUNICATION; MENOPAUSE; MENSTRUATION DISORDER; NURSE ATTITUDE; NURSING ASSESSMENT; ONCOLOGY NURSING; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; STANDARD; STATISTICS; SURVIVOR;

AFTERCARE; AGE FACTORS; ANTINEOPLASTIC AGENTS; COMMUNICATION; FEMALE; HUMANS; INFERTILITY, FEMALE; MENOPAUSE; MENSTRUATION DISTURBANCES; NURSE'S ROLE; NURSING ASSESSMENT; ONCOLOGIC NURSING; PATIENT EDUCATION; QUALITY OF HEALTH CARE; QUALITY OF LIFE; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS; SURVIVORS; TOTAL QUALITY MANAGEMENT;

EID: 33746010221     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200603002-00021     Document Type: Review

References (52)

1. Averette HE, et al. Effects of cancer chemotherapy on gonadal function and reproductive capacity. CA Cancer J Clin 1990;40(4):199-209.
2. Bath LE, et al. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 2002;109(2):107-14.
3. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update 2001;7(6):535-43.
4. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000;169(1-2):123-31.
5. Knobf MT. Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncol Nurs Forum 1998;25(9):1519-30.
6. Whitehead E, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983;52(6):988-93.
7. Gershenson DM. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988;6(2):270-5.
8. Franchi-Rezgui P, et al. Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 2003;4(2):116-20.
9. Fornier MN, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005;104(8):1575-9.
10. Byrne J, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 1987;317(21):1315-21.
11. Chapman RM, et al. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA 1979;242(17):1877-81.
12. Mehta RR, et al. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 1992;20(2):125-32.
13. Goodwin PJ, et al. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 1999;17(8):2365-70.
14. Lower EE, et al. The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 1999;8(7):949-54.
15. Cimprich B, et al. Age at diagnosis and quality of life in breast cancer survivors. Cancer Pract 2002;10(2):85-93.
16. Northouse LL. Breast cancer in younger women: effects on interpersonal and family relations. J Natl Cancer Inst Monogr 1994(16):183-90.
17. Bloom JR, Kessler L. Risk and timing of counseling and support interventions for younger women with breast cancer. J Natl Cancer Inst Monogr 1994(16):199-206.
18. Sammarco A. Psychosocial stages and quality of life of women with breast cancer. Cancer Nurs 2001;24(4):272-7.
19. Lewis FM, et al. The functioning of single women with breast cancer and their school-aged children. Cancer Pract 1996;4(1):15-24.
20. Ganz PA, et al. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16(2):501-14.
21. Ganz PA, et al. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 2003;21(22):4184-93.
22. Knobf MT. The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs 2001;24(3):201-10.
23. Knobf MT. Carrying on: the experience of premature menopause in women with early stage breast cancer. Nurs Res 2002;51(1):9-17.
24. Dunn J, Steginga SK. Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology 2000;9(2):137-46.
25. Bergmark K, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999;340(18):1383-9.
26. Cartwright-Alcarese F. Addressing sexual dysfunction following radiation therapy for a gynecologic malignancy. Oncol Nurs Forum 1995;22(8):1227-32.
27. Chapman RM, et al. Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function. JAMA 1979;242(17):1882-4.
28. Lamb MA. Effects of cancer on the sexuality and fertility of women. Semin Oncol Nurs 1995;11(2):120-7.
29. Lamb MA, Sheldon TA. The sexual adaptation of women treated for endometrial cancer. Cancer Pract 1994;2(2):103-13.
30. Ganz PA, et al. Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 1999;17(8):2371-80.
31. Ganz PA, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004;96(5):376-87.
32. Schag CA, et al. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 1993;11(4):783-93.
33. Spencer SM, et al. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychol 1999;18(2):159-68.
34. Harwood KV. Advances in endocrine therapy for breast cancer: considering efficacy, safety, and quality of life. Clin J Oncol Nurs 2004;8(6):629-37.
35. Schnipper HH. Life after breast cancer. J Clin Oncol 2001;19(15):3581-4.
36. Wilmoth MC. The aftermath of breast cancer: an altered sexual self. Cancer Nurs 2001;24(4):278-86.
37. Duffy CM, et al. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 2005;23(4):766-73.
38. Schover LR, et al. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999;86(4):697-709.
39. Simon B, et al. Preserving fertility after cancer. CA Cancer J Clin 2005;55(4):211-28; quiz 63-4.
40. Dow KH, Kuhn D. Fertility options in young breast cancer survivors: a review of the literature. Oncol Nurs Forum 2004;31(3):E46-53.
41. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10(3):251-66.
42. Falcone T, et al. Ovarian function preservation in the cancer patient. Fertil Steril 2004;81(2):243-57.
43. Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod 2004;19(3):477-80.
44. Oktay K, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003;18(1):90-5.
45. Oktay K, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23(19):4347-53.
46. Grundy R, et al. Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas. Arch Dis Child 2001;84(4):355-9.
47. Meirow D, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353(3):318-21.
48. Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 2005(34):40-3.
49. Fox KR, et al. Preventing chemotherapy-related amenorrhea using leuprolide during adjuvant chemotherapy for earlystage breast cancer. Proceedings of the American Society of Clinical Oncology 2003;22:13. [abstract 50].
50. Hershlag A, Schuster MW. Return of fertility after autologous stem cell transplantation. Fertil Steril 2002;77(2):419-21.
51. Lo Presti A, et al. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol 2004;113 Suppl 1:S33-40.
52. Oksuzoglu B, Guler N. An infertile patient with breast cancer who delivered a healthy child under adjuvant tamoxifen therapy. Eur J Obstet Gynecol Reprod Biol 2002;104(1):79.